Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,966.67p
   
  • Change Today:
    -58.33p
  • 52 Week High: 2,200.00
  • 52 Week Low: 1,366.67
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 73,058
  • Market Cap: £102.76m

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 7.5% 0.0%
Div Cover 1.0 n/a
Op Mrgn 77.8% 76.2%
ROCE 78.6%  
Latest F'cast
P/E 13.8 n/a
PEG 42.6 n/a
Pr/Revenue 8.1 n/a
Pr/Book 9.2  
Latest F'cast
Revenue -1.1% n/a
PBT 1.3% -100.0%
EPS 0.3% n/a
DPS n/a -100.0%

Bioventix Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%
30-Jun-23 12.82 10.13 160.63p 24.0 2.7 +9% 152.00p 3.9%
30-Jun-24 13.61 10.60 155.12p 28.4 n/a -3% 155.00p 3.5%
30-Jun-25 13.12 10.10 145.27p 18.9 n/a -6% 150.00p 5.5%
30-Jun-26 12.97 10.23 145.74p 11.1 n/a 0% 150.00p 9.3%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Bioventix Forecasts

Bioventix Forecasts data is not available for this company.

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Bioventix Company Announcements

Holding(s) in Company 30-Oct-2026 17:00 RNS
Results for the year ended 30 June 2026 26-Oct-2026 07:00 RNS
Director Dealing 24-Jun-2026 16:10 RNS

Latest Bioventix Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Bioventix Market Data

Currency UK Pounds
Share Price 1,966.67p
Change Today -58.33p
% Change -2.88 %
52 Week High 2,200.00
52 Week Low 1,366.67
Volume 73,058
Shares Issued 5.22m
Market Cap £102.76m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
81.37% below the market average81.37% below the market average81.37% below the market average81.37% below the market average81.37% below the market average
85.37% below the sector average85.37% below the sector average85.37% below the sector average85.37% below the sector average85.37% below the sector average
Price Trend
92.1% below the market average92.1% below the market average92.1% below the market average92.1% below the market average92.1% below the market average
67.44% below the sector average67.44% below the sector average67.44% below the sector average67.44% below the sector average67.44% below the sector average
Income Not Available
Growth
65.63% below the market average65.63% below the market average65.63% below the market average65.63% below the market average65.63% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Bioventix Dividends

  Latest Previous
  2nd Interim Interim
Ex-Div 05-Nov-26 09-Apr-26
Paid 20-Nov-26 24-Apr-26
Amount 80.00p 70.00p

Trades for 05-Nov-2026

Time Volume / Share Price
14:48 600 @ 1,966.25p
14:42 224 @ 1,966.10p
14:42 150 @ 1,992.50p
14:38 775 @ 1,992.00p
14:33 118 @ 1,966.10p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page